E
Evozyne
Biotech & Life Sciences · Chicago, United States · Founded 2020
Generative AI-powered drug discovery platform and product development MoreLess
Evozyne is a pioneering biotech startup focused on creating novel protein systems to address some of the world's most pressing health challenges. The company leverages the natural principles of evolution to develop advanced proteins, which they refer to as "Natural Machines." These proteins are designed to perform specific functions at an unprecedented level of efficiency, paving the way for new therapeutic solutions and commercial-scale applications.
Evozyne primarily serves clients in the pharmaceutical and biotechnology sectors, including companies involved in drug discovery and development. By offering innovative protein solutions, Evozyne aims to enhance the efficacy and safety of therapeutic products, thereby contributing to a healthier world.
Operating in the highly specialized market of protein engineering and synthetic biology, Evozyne stands out due to its unique approach of using evolutionary principles to solve complex biological problems. This market is characterized by rapid advancements and high demand for cutting-edge solutions that can address unmet medical needs.
Evozyne's business model revolves around research and development (R&D) and strategic partnerships. The company invests heavily in R&D to continuously innovate and refine its protein systems. Revenue is generated through collaborations with pharmaceutical companies, licensing agreements, and potentially through the commercialization of proprietary therapeutic products developed using their technology.
The leadership team at Evozyne includes experts with extensive backgrounds in molecular engineering, computational biology, and drug discovery. Their scientific advisory board comprises distinguished professors and researchers from top institutions, ensuring that the company remains at the forefront of scientific innovation.
In summary, Evozyne is a biotech startup that creates advanced protein systems to solve critical health challenges, serving pharmaceutical and biotech clients through a robust R&D-focused business model.
Keywords: biotech, protein engineering, synthetic biology, drug discovery, therapeutic development, evolution, R&D, pharmaceutical, innovation, health solutions.
Company overview
Evozyne company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2020
- Headquarters
- Chicago, United States
- Employees
- 54
- Open positions
- 2
- Dealroom signal
- 70.4
Valuation & funding
Evozyne funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Sep 2023 | $81M | $324M | Valor Equity Partners · NVentures · Fidelity Investments · OrbiMed | ↗ |
| SERIES AOther financing | Apr 2021 | $54M | $217M | Undisclosed | — |
| EARLY VCOther financing | Apr 2020 | $9.2M | $37M | Undisclosed | — |
| SPINOUTOther financing | Jan 2020 | $0 | — | The University of Chicago | — |
Growth signals
Evozyne website traffic
Latest recorded traffic for Evozyne is 2.7K monthly website visits, up 35% over the last three months. Evozyne's team grew 0% over the past year.
Hiring
Open positions at Evozyne
Current openings linked to this company in Dealroom.
Comparisons
Evozyne compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Evozyne's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Evozyne has talent and traffic
team presence
In the news
Latest news about Evozyne
Recent press, funding announcements, and product moves mentioning Evozyne — open to read from the original sources.
Market sentiment
What the market is saying about Evozyne
An AI-synthesized read of the highest-engagement posts about Evozyne on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Evozyne’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.













